Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ... - MarketWatch (press release)
Posted by admin / Under Diabetes Mellitus Type 2
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ... MarketWatch (press release) ONGLYZA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ONGLYZA should not be used for ... Bristol-Myers, AstraZeneca Commence Saxagliptin Assessment Of Vascular ... Bristol-Myers Squibb, AstraZeneca announce postmarketing study for Onglyza |
Published on Tuesday 9th of March 2010 07:21:26 PM




Share this!